Sie suchten nach: ovariestimulation (Dänisch - Englisch)

en vis grad af ovarieforstørrelse er en forventet effekt af kontrolleret ovariestimulation.
a certain degree of ovarian enlargement is an expected effect of controlled ovarian stimulation.

ovarie hyperstimulationssyndrom (ohss) forekomme under eller efter ovariestimulation.
ovarian hyperstimulation syndrome (ohss) may occur during or following ovarian stimulation.

under amning kan sekretion af prolaktin medføre en ringe prognose for ovariestimulation.
during lactation, the secretion of prolactin can entail a poor prognosis to ovarian stimulation.

hidtil er der begrænset erfaring med behandling med cetrotide 3 mg under gentaget ovariestimulation.
there is limited experience up to now with the administration of cetrotide 3 mg during a repeated ovarian stimulation procedure.

under fertilitetsbehandling anvendes ovariestimulation normalt til at få ovarierne til at producere mere end ét æg.
during fertility treatment, ovarian stimulation is normally used to make the ovaries produce more than one egg.

det forventes, at de samme bivirkninger vil ses ved orgalutranbehandling med anvendelse af corifollitropin alfa til ovariestimulation.
the adverse reactions with orgalutran using corifollitropin alfa for ovarian stimulation are expected to be similar.

kvinder som gennemgår ovariestimulation med henblik på multipel follikeludvikling i forbindelse med in vitro fertilisation eller anden assisteret reproduktionsteknologi
women undergoing ovarian stimulation for multiple follicular development prior to in vitro fertilisation or other assisted reproductive technologies

forebyggelse af præmatur ægløsning hos patienter, der gennemgår kontrolleret ovariestimulation, efterfulgt af ægudtagning og assisteret reproduktionsteknik.
prevention of premature ovulation in patients undergoing a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

ovariestimulation med follikelstimulerende hormon (fsh) eller corifollitropin kan starte på menstruationens 2. eller 3. dag.
ovarian stimulation with follicle stimulating hormone (fsh) or corifollitropin may start at day 2 or 3 of your period.

cetrotide 3 mg anvendes til at forebygge præmatur ægløsning hos patienter, der gennemgår kontrolleret ovariestimulation, efterfulgt af ægudtagning og assisteret reproduktionsteknik.
cetrotide 3 mg is used to prevent premature ovulation during a controlled ovarian stimulation, followed by oocyte pick-up and assisted reproductive techniques.

patienter, som modtager ovariestimulation, har en øget risiko for at udvikle ovariehyperstimulationssyndrom (ohss) forårsaget af multipel follikeludvikling.
patients undergoing ovarian stimulation are at an increased risk of developing ovarian hyperstimulation syndrome (ohss) due to multiple follicular development.

15 under eller efter hormonel ovariestimulation kan der udvikles ovariehyperstimulationssyndrom.dette relateres til gonadotropin stimulationsproceduren.læs venligst indlægssedlen for den gonadotropinholdige medicin, der er ordineret til dig.
15 during or following hormonal stimulation of the ovaries ovarian hyperstimulation syndrome may develop; this syndrome is related to the stimulation procedure with gonadotrophins; please refer to the package leaflet of the gonadotrophin-containing medicine prescribed for you.

behandlingen bør indledes på den 6. dag med ovariestimulation, dvs.6 dage efter starten på fsh-indgivelse (follikelstimulerende hormon) .
treatment should start on day 6 of ovarian stimulation, this is 6 days after the start of fsh (follicle stimulating hormone) administration.

cetrotide 0, 25 mg gives dagligt enten om morgenen eller om aftenen startende på dag 5 eller 6 efter ovariestimulationen, indtil dagen for den planlagte ovulationsinduktion.
cetrotide 0.25 mg is given daily, either in the morning or in the evening, starting on day 5 or 6 of ovarian stimulation, until the day of planned ovulation induction.